Department Of Neurology
Investigator
Mary Welch, MD
Phone
212-342-0571
Email
mw2517@cumc.columbia.edu
Mary Welch, MD is an Associate Professor of Neurology at CUMC, in the Division of Neuro-Oncology. Dr. Welch graduated from Chicagos' Northwestern Feinberg School of Medicine. She completed neurology residency here at Columbia, followed by sub-specialty training in neuro-oncology at Memorial Sloan-Kettering Cancer Center. In her second year of fellowship, she earned a Comparative Effectiveness Research Award to attend Columbia's Summer Research Institute at Mailman School of Public Health.

Upon completing her training, Dr. Welch worked for several years as a practicing neuro-oncologist and Assistant Professor of Neurology at Montefiore Medical Center in the Bronx. There, she served as principal investigator for numerous phase I and II clinical trials for the treatment of primary and metastatic brain cancer. She also developed a strong research interest in improving patient access to both standard and investigational therapies. In addition to seeing both inpatient and outpatient neuro-oncology patients, Dr. Welch maintains an active research program within the Division of Neuro-Oncology.

Clinical Studies Managed By This Investigator:
Condition Study Title
Brain Tumors [ CLOSED ] INdividualized Screening trial of Innovative Glioblastoma Therapy (INSIGhT)
Brain Tumors [ CLOSED ] Study of DSP-7888 in Combination with Bevacizumab in Patients with Recurrent or Progressive Glioblastoma
Neurological Disorders [ CLOSED ] Collection of Tissue and Medical Information from Research Subjects with Neurological Disorders
Brain Tumors [ CLOSED ] Study Treatment (INO-5401 and INO-9012 delivered by electoporation device in combination with REGN2810) in Subjects with Glioblastoma
Brain Tumors [ CLOSED ] Study of Armodafinil (Nuvigil) to Reduce Cancer-Related Fatigue in Patients with High-Grade Glioma (HGG)
Brain Tumors [ CLOSED ] Study of Cediranib and Olaparib Compared to Bevacizumab in Patients with Recurrent Glioblastoma
Cancer [ CLOSED ] CB-839 With Radiation Therapy and Temozolomide in Participants With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma
Brain Tumors Study of Vismodegib and GSK2256098 to Shrink Tumors in Patients with Meningioma
Brain Cancer Study of Vismodegib and GSK2256098 to Shrink Tumors in Patients with Meningioma
Brain Cancer Study of DSP-0390 in Patients with Recurrent High-Grade Glioma
Brain Tumors Study of DSP-0390 in Patients with Recurrent High-Grade Glioma